| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Rad Power Bikes | Transportation Ridesharing | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $273.73M | Series D | 10/28/2021 | $148.06M | $1.62B | $9.58 | Fidelity Management, T. Rowe Price, Counterpoint Global, Vulcan Capital, Durable Capital Partners, The Rise Fund | ||||
 | Talos | Fintech Blockchain | Low | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $196.05M | Series B | 1/29/2026 | $136.86M | $1.5B | $50.02 | General Atlantic, Stripes, BNY Mellon, Citi, Wells Fargo, DRW Venture Capital, SCB 10x, Matrix Capital Management, Fin Capital, Voyager Digital, Graticule Asset Management Asia, LeadBlock Partners, Robinhood Markets, Sony Innovation Fund, IMC Trading, QCP, Karatage, Andreessen Horowitz, Fidelity, Notation Capital, Initialized Capital, Illuminate Financial, Castle Island Ventures, Galaxy Ventures, PayPal Ventures, Raptor Group, TenSquared | ||||
 | Xaira Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $1B | Series A | 4/23/2024 | $500M | $2.65B | $2.50 | ARCH Venture Partners, Foresite Capital, F-Prime, NEA, Sequoia Capital, Lux Capital, Lightspeed Venture Partners, Menlo Ventures, Two Sigma Ventures, Parker Institute for Cancer Immunotherapy, Byers Capital, Rsquared, SV Angel, AIM13, Breyer Capital, Deviation Capital, Foresite Labs, JSL Health Capital, Longwood Fund, Sahsen Ventures, WRF Capital | ||||
 | ArsenalBio | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $2.44B | Series C | 9/4/2024 | $327.5M | $1.66B | $18.58 | ARCH Venture Partners, Milky Way Investments Group, Regeneron Ventures, NVIDIA, Luma Group, T. Rowe Price Associates, Rock Springs Capital, Parker Institute for Cancer Immunotherapy, SoftBank, Bristol-Myers Squibb, Westlake Village BioPartners, Kleiner Perkins, Byers Capital, Hitachi Ventures | ||||
 | Augury | Industrial Manufacturing | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $359.09M | Series F | 2/19/2025 | $75M | $1.1B | $9.99 | Lightrock, Insight Partners, Eclipse Ventures, Qumra Capital, La Maison Partners, SE Ventures, Qualcomm Ventures, Lerer Hippeau, Munich Re Ventures | ||||
 | Blitzy | Enterprise Software Software Development | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $208.69M | Series Growth-1 | 5/5/2026 | $196.08M | $1.39B | $66.97 | Northzone, PSG, Battery Ventures, Jump Capital, Morgan Creek Digital, Defiant, Flybridge, Link Ventures, NFX, Picus Capital, Venture Guides, Liberty Mutual Strategic Ventures, Erie Strategic Ventures, BAL Ventures, Litquidity Capital, New York Life Ventures | ||||
 | CodeRabbit | Enterprise Software Software Development | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $231.01M | Series C | 8/12/2026 | $143M | $1.5B | $58.21 | Atomico, Smash Capital, BMW i Ventures, Datadog, Hirtle & Co., SineWave Ventures, Scenic Management, CRV, Scale Venture Partners, Flex Capital, Pelion Venture Partners, Harmony Partners, Engineering Capital | ||||
 | Eve | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $162.45M | Series B-1 | 10/1/2025 | $14.55M | $1B | $3.18 | Spark Capital, Andreessen Horowitz, Lightspeed Venture Partners, Menlo Ventures | ||||
 | Icertis | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $556.75K | -- | 2 | Not available | -- | -- | $280.86M | Series F | 3/11/2021 | $80M | $2.85B | $82.64 | B Capital Group, Greycroft, Meritech Capital Partners, Premji Invest, PSP Growth, e.ventures | ||||
 | Jeeves | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $402.01M | Series 1 | 7/30/2026 | $67.65M | $2.6B | $4.24 | Undisclosed Investors | ||||
 | Kin | Fintech Insurance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $298M | Series E | 9/8/2025 | $50M | $2.05B | $113.01 | QED Investors, Activate Capital | ||||
 | Ledgebrook | Fintech Blockchain Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $357.77M | Series D | 6/22/2026 | $200M | $2.59B | $148.72 | Undisclosed Investors | ||||
 | LiveKit | Consumer & Lifestyle Consumer Electronics | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $221.3M | Series C-1 | 8/3/2026 | $40M | $1.45B | $5.08 | Undisclosed Investors | ||||
 | Mammoth Biosciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $379.07M | Series D-3 | 12/2/2025 | $15M | $1.35B | $13.45 | Undisclosed Investors | ||||
 | May Mobility | Transportation Autonomous Vehicles | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $209.27K | -- | 1 | Not available | -- | -- | $306.99M | Series E | 4/15/2025 | $6.01M | $1.29B | $12.15 | ITOCHU Corporation | ||||
 | Meter | Enterprise Software Cloud / Networking Infrastructure | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $1M | -- | 1 | Not available | -- | -- | $304.01M | Series C-1 | 9/17/2025 | $49.84M | $1.93B | $93.42 | Undisclosed Investors | ||||
 | Modern Treasury | Fintech Payments | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $133.28M | Series C | 10/6/2021 | $85M | $2.12B | $83.84 | Altimeter Capital, Benchmark, Quiet Capital | ||||
 | Nourish | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $214.16M | Series C | 5/19/2026 | $100M | $1.75B | $12.47 | Menlo Ventures, Thrive Capital, Index Ventures, J.P. Morgan, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak, Operator Partners | ||||
 | Parallel Web Systems | Enterprise Software Software Development | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $385.55M | Series B-2 | 7/6/2026 | $150M | $2.64B | $256.20 | Undisclosed Investors | ||||
 | ReCharge | Consumer & Lifestyle E-commerce | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $2.88M | -- | 1 | Not available | -- | -- | $477.61M | Series B-3 | 5/6/2021 | $129M | $2.1B | $10.28 | Summit Partners, ICONIQ Growth, Bain Capital Ventures | ||||
 | Science Corporation | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $100.00K | $100.00K | 1 | 1 | Not available | -- | -- | $494.02M | Series C | 3/5/2026 | $230.05M | $1.5B | $8.36 | Khosla Ventures, Lightspeed Venture Partners, Y Combinator, In-Q-Tel, Quiet Capital, Mangusta Capital, Octant Ventures, RRE Ventures | ||||
 | SiMa.ai | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $731.7M | Series C | 8/17/2026 | $524.9M | $1.59B | $9.18 | Undisclosed Investors | ||||
 | Tekion | Consumer & Lifestyle Consumer & Lifestyle Enterprise Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $1.4M | -- | 1 | Not available | -- | -- | $464.8M | Series D | 10/6/2021 | $250.01M | $3.5B | $9.37 | Alkeon Capital, Durable Capital Partners, Hyundai Motor Company, Advent International, Index Ventures | ||||
 | Workrise | Enterprise Software Human Resources | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | $75.00 | -29.44% | -29.44% | $786.71M | Series E | 5/20/2021 | $300M | $2.9B | $419.18 | Baillie Gifford, Franklin Templeton, Founders Fund, Bedrock Capital, Andreessen Horowitz, Moore Strategic Ventures, 137 Ventures, Brookfield Growth Partners | ||||